Boston Scientific Corporation (BSX)
USD 104.93
(1.69%)
USD 104.93
(1.69%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.13 Billion USD | 8.21% |
| 2022 | 32.47 Billion USD | 0.74% |
| 2021 | 32.23 Billion USD | 4.72% |
| 2020 | 30.77 Billion USD | 0.7% |
| 2019 | 30.56 Billion USD | 45.56% |
| 2018 | 20.99 Billion USD | 10.28% |
| 2017 | 19.04 Billion USD | 5.22% |
| 2016 | 18.09 Billion USD | -0.2% |
| 2015 | 18.13 Billion USD | 7.74% |
| 2014 | 16.83 Billion USD | 0.57% |
| 2013 | 16.73 Billion USD | -2.45% |
| 2012 | 17.15 Billion USD | -19.43% |
| 2011 | 21.29 Billion USD | -3.79% |
| 2010 | 22.12 Billion USD | -12.11% |
| 2009 | 25.17 Billion USD | -7.03% |
| 2008 | 27.08 Billion USD | -13.2% |
| 2007 | 31.19 Billion USD | 0.32% |
| 2006 | 31.09 Billion USD | 279.4% |
| 2005 | 8.19 Billion USD | 0.32% |
| 2004 | 8.17 Billion USD | 43.36% |
| 2003 | 5.69 Billion USD | 28.07% |
| 2002 | 4.45 Billion USD | 11.98% |
| 2001 | 3.97 Billion USD | 15.96% |
| 2000 | 3.42 Billion USD | -4.06% |
| 1999 | 3.57 Billion USD | -8.24% |
| 1998 | 3.89 Billion USD | 97.82% |
| 1997 | 1.96 Billion USD | 30.14% |
| 1996 | 1.51 Billion USD | 40.66% |
| 1995 | 1.07 Billion USD | 148.96% |
| 1994 | 431.8 Million USD | 33.6% |
| 1993 | 323.2 Million USD | 8.06% |
| 1992 | 299.1 Million USD | 117.69% |
| 1991 | 137.4 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 38.07 Billion USD | 2.61% |
| 2024 Q1 | 36.66 Billion USD | 4.36% |
| 2024 Q2 | 37.1 Billion USD | 1.2% |
| 2023 Q2 | 33.6 Billion USD | 2.16% |
| 2023 FY | 35.13 Billion USD | 8.21% |
| 2023 Q1 | 32.89 Billion USD | 1.3% |
| 2023 Q4 | 35.13 Billion USD | 3.21% |
| 2023 Q3 | 34.04 Billion USD | 1.32% |
| 2022 Q1 | 32.33 Billion USD | 0.33% |
| 2022 Q2 | 32.19 Billion USD | -0.45% |
| 2022 Q4 | 32.47 Billion USD | 1.63% |
| 2022 FY | 32.47 Billion USD | 0.74% |
| 2022 Q3 | 31.94 Billion USD | -0.75% |
| 2021 Q3 | 31.87 Billion USD | 2.27% |
| 2021 Q1 | 30.9 Billion USD | 0.4% |
| 2021 FY | 32.23 Billion USD | 4.72% |
| 2021 Q2 | 31.16 Billion USD | 0.87% |
| 2021 Q4 | 32.23 Billion USD | 1.11% |
| 2020 Q1 | 30.11 Billion USD | -1.48% |
| 2020 Q3 | 30.84 Billion USD | 0.07% |
| 2020 Q4 | 30.77 Billion USD | -0.22% |
| 2020 FY | 30.77 Billion USD | 0.7% |
| 2020 Q2 | 30.82 Billion USD | 2.36% |
| 2019 Q4 | 30.56 Billion USD | 14.24% |
| 2019 Q1 | 23.8 Billion USD | 13.35% |
| 2019 Q2 | 24.3 Billion USD | 2.13% |
| 2019 Q3 | 26.75 Billion USD | 10.07% |
| 2019 FY | 30.56 Billion USD | 45.56% |
| 2018 Q3 | 20.37 Billion USD | 3.89% |
| 2018 Q1 | 19.2 Billion USD | 0.84% |
| 2018 FY | 20.99 Billion USD | 10.28% |
| 2018 Q2 | 19.61 Billion USD | 2.16% |
| 2018 Q4 | 20.99 Billion USD | 3.04% |
| 2017 Q3 | 18.63 Billion USD | 1.38% |
| 2017 FY | 19.04 Billion USD | 5.22% |
| 2017 Q1 | 17.94 Billion USD | -0.85% |
| 2017 Q2 | 18.38 Billion USD | 2.45% |
| 2017 Q4 | 19.04 Billion USD | 2.17% |
| 2016 Q1 | 17.71 Billion USD | -2.29% |
| 2016 Q3 | 17.69 Billion USD | -0.79% |
| 2016 Q2 | 17.83 Billion USD | 0.68% |
| 2016 Q4 | 18.09 Billion USD | 2.25% |
| 2016 FY | 18.09 Billion USD | -0.2% |
| 2015 Q3 | 18.21 Billion USD | 6.38% |
| 2015 Q1 | 16.47 Billion USD | -2.13% |
| 2015 FY | 18.13 Billion USD | 7.74% |
| 2015 Q4 | 18.13 Billion USD | -0.45% |
| 2015 Q2 | 17.12 Billion USD | 3.95% |
| 2014 Q1 | 16.33 Billion USD | -2.38% |
| 2014 FY | 16.83 Billion USD | 0.57% |
| 2014 Q3 | 16.71 Billion USD | 1.46% |
| 2014 Q2 | 16.47 Billion USD | 0.87% |
| 2014 Q4 | 16.83 Billion USD | 0.67% |
| 2013 Q2 | 16.99 Billion USD | 1.39% |
| 2013 Q1 | 16.76 Billion USD | -2.28% |
| 2013 FY | 16.73 Billion USD | -2.45% |
| 2013 Q4 | 16.73 Billion USD | -1.08% |
| 2013 Q3 | 16.91 Billion USD | -0.46% |
| 2012 Q1 | 21.18 Billion USD | -0.49% |
| 2012 Q2 | 17.99 Billion USD | -15.06% |
| 2012 Q3 | 16.83 Billion USD | -6.43% |
| 2012 Q4 | 17.15 Billion USD | 1.88% |
| 2012 FY | 17.15 Billion USD | -19.43% |
| 2011 Q2 | 21.55 Billion USD | -2.2% |
| 2011 Q1 | 22.04 Billion USD | -0.38% |
| 2011 Q3 | 21.5 Billion USD | -0.26% |
| 2011 Q4 | 21.29 Billion USD | -0.99% |
| 2011 FY | 21.29 Billion USD | -3.79% |
| 2010 Q2 | 23.01 Billion USD | 0.73% |
| 2010 Q4 | 22.12 Billion USD | -1.59% |
| 2010 Q3 | 22.48 Billion USD | -2.32% |
| 2010 FY | 22.12 Billion USD | -12.11% |
| 2010 Q1 | 22.85 Billion USD | -9.23% |
| 2009 FY | 25.17 Billion USD | -7.03% |
| 2009 Q4 | 25.17 Billion USD | -4.01% |
| 2009 Q3 | 26.22 Billion USD | 0.14% |
| 2009 Q2 | 26.19 Billion USD | 0.34% |
| 2009 Q1 | 26.1 Billion USD | -3.81% |
| 2008 Q3 | 29.82 Billion USD | -0.25% |
| 2008 Q1 | 30.34 Billion USD | -2.73% |
| 2008 FY | 27.08 Billion USD | -13.2% |
| 2008 Q4 | 27.13 Billion USD | -9.01% |
| 2008 Q2 | 29.9 Billion USD | -1.47% |
| 2007 Q3 | 31.33 Billion USD | 0.22% |
| 2007 FY | 31.19 Billion USD | 0.32% |
| 2007 Q1 | 31.06 Billion USD | -0.09% |
| 2007 Q2 | 31.26 Billion USD | 0.63% |
| 2007 Q4 | 31.19 Billion USD | -0.44% |
| 2006 Q4 | 31.09 Billion USD | 1.12% |
| 2006 Q1 | 9.1 Billion USD | 11.14% |
| 2006 FY | 31.09 Billion USD | 279.4% |
| 2006 Q2 | 30.61 Billion USD | 236.05% |
| 2006 Q3 | 30.75 Billion USD | 0.46% |
| 2005 FY | 8.19 Billion USD | 0.32% |
| 2005 Q1 | 7.81 Billion USD | -4.3% |
| 2005 Q2 | 8.08 Billion USD | 3.38% |
| 2005 Q3 | 8.07 Billion USD | -0.09% |
| 2005 Q4 | 8.19 Billion USD | 1.49% |
| 2004 Q3 | 7.98 Billion USD | 7.41% |
| 2004 Q2 | 7.43 Billion USD | 27.17% |
| 2004 Q4 | 8.17 Billion USD | 2.34% |
| 2004 Q1 | 5.84 Billion USD | 2.54% |
| 2004 FY | 8.17 Billion USD | 43.36% |
| 2003 Q2 | 4.92 Billion USD | 6.7% |
| 2003 Q3 | 5.2 Billion USD | 5.73% |
| 2003 Q4 | 5.69 Billion USD | 9.53% |
| 2003 FY | 5.69 Billion USD | 28.07% |
| 2003 Q1 | 4.61 Billion USD | 3.64% |
| 2002 Q3 | 4.26 Billion USD | 3.64% |
| 2002 Q4 | 4.45 Billion USD | 4.29% |
| 2002 FY | 4.45 Billion USD | 11.98% |
| 2002 Q1 | 4.01 Billion USD | 1.03% |
| 2002 Q2 | 4.11 Billion USD | 2.54% |
| 2001 FY | 3.97 Billion USD | 15.96% |
| 2001 Q2 | 3.59 Billion USD | 1.84% |
| 2001 Q4 | 3.97 Billion USD | 5.58% |
| 2001 Q3 | 3.76 Billion USD | 4.85% |
| 2001 Q1 | 3.52 Billion USD | 2.86% |
| 2000 FY | 3.42 Billion USD | -4.06% |
| 2000 Q1 | 3.51 Billion USD | -1.62% |
| 2000 Q4 | 3.42 Billion USD | 0.41% |
| 2000 Q2 | 3.48 Billion USD | -0.88% |
| 2000 Q3 | 3.41 Billion USD | -2.01% |
| 1999 Q2 | 3.74 Billion USD | -3.35% |
| 1999 Q1 | 3.87 Billion USD | -0.43% |
| 1999 FY | 3.57 Billion USD | -8.24% |
| 1999 Q3 | 3.63 Billion USD | -2.86% |
| 1999 Q4 | 3.57 Billion USD | -1.84% |
| 1998 Q1 | 2.12 Billion USD | 7.99% |
| 1998 FY | 3.89 Billion USD | 97.82% |
| 1998 Q3 | 3.99 Billion USD | 79.17% |
| 1998 Q4 | 3.89 Billion USD | -2.54% |
| 1998 Q2 | 2.22 Billion USD | 4.9% |
| 1997 FY | 1.96 Billion USD | 30.14% |
| 1997 Q1 | 1.55 Billion USD | 3.14% |
| 1997 Q2 | 1.74 Billion USD | 11.7% |
| 1997 Q3 | 1.85 Billion USD | 6.64% |
| 1997 Q4 | 1.96 Billion USD | 5.92% |
| 1996 Q4 | 1.51 Billion USD | 11.41% |
| 1996 Q3 | 1.35 Billion USD | 7.91% |
| 1996 Q2 | 1.25 Billion USD | 1.3% |
| 1996 FY | 1.51 Billion USD | 40.66% |
| 1996 Q1 | 1.24 Billion USD | 15.5% |
| 1995 Q1 | 871.1 Million USD | 101.74% |
| 1995 Q2 | 890.8 Million USD | 2.26% |
| 1995 Q3 | 831.1 Million USD | -6.7% |
| 1995 Q4 | 1.07 Billion USD | 29.35% |
| 1995 FY | 1.07 Billion USD | 148.96% |
| 1994 Q1 | 351.1 Million USD | 8.63% |
| 1994 Q3 | 396.2 Million USD | 7.17% |
| 1994 Q2 | 369.7 Million USD | 5.3% |
| 1994 Q4 | 431.8 Million USD | 8.99% |
| 1994 FY | 431.8 Million USD | 33.6% |
| 1993 FY | 323.2 Million USD | 8.06% |
| 1993 Q4 | 323.2 Million USD | 4.39% |
| 1993 Q1 | 320.2 Million USD | 7.05% |
| 1993 Q2 | 306.6 Million USD | -4.25% |
| 1993 Q3 | 309.6 Million USD | 0.98% |
| 1992 Q1 | 151 Million USD | 9.9% |
| 1992 FY | 299.1 Million USD | 117.69% |
| 1992 Q3 | 287.1 Million USD | 6.89% |
| 1992 Q2 | 268.6 Million USD | 77.88% |
| 1992 Q4 | 299.1 Million USD | 4.18% |
| 1991 FY | 137.4 Million USD | 0.0% |
| 1991 Q4 | 137.4 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 52.009% |
| Allurion Technologies Inc. | 71.71 Million USD | -48895.984% |
| Artivion, Inc. | 792.39 Million USD | -4334.141% |
| Avanos Medical, Inc. | 1.69 Billion USD | -1976.105% |
| Butterfly Network, Inc. | 304.27 Million USD | -11447.487% |
| Butterfly Network, Inc. | 304.27 Million USD | -11447.487% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | -185.68% |
| CONMED Corporation | 2.3 Billion USD | -1427.638% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | -275.256% |
| Paragon 28, Inc. | 340.69 Million USD | -10212.916% |
| Glaukos Corporation | 940.41 Million USD | -3636.227% |
| Globus Medical, Inc. | 5.08 Billion USD | -590.826% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -5091.405% |
| Integer Holdings Corporation | 2.94 Billion USD | -1094.025% |
| Medtronic plc | 89.98 Billion USD | 60.952% |
| Myomo, Inc. | 14.58 Million USD | -240861.74% |
| Nevro Corp. | 635.71 Million USD | -5427.022% |
| Owlet, Inc. | 44.12 Million USD | -79531.938% |
| Penumbra, Inc. | 1.55 Billion USD | -2157.655% |
| Vicarious Surgical Inc. | 119.86 Million USD | -29213.222% |
| Smith & Nephew plc | 9.98 Billion USD | -251.817% |
| STERIS plc | 11.06 Billion USD | -217.579% |
| Stryker Corporation | 39.91 Billion USD | 11.966% |
| Vapotherm, Inc. | 77.61 Million USD | -45168.433% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | -63.447% |